Conventional and non-conventional coronary risk factors in male premature coronary artery disease patients already having a low Framingham risk score

Acta Cardiologica

Volumn 63, Issue 5, 2008, Pages 623-628

  Koz, Cem ^a   Baysan, Oben ^a   Hasimi, Adnan ^a   Cihan, Murat ^a   Uzun, Mehmet ^a   Yokusoglu, Mehmet ^a   Sag, Cereal ^a   Isik, Ersoy ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Coronary risk factors; Low Framingham risk score; Premature coronary artery disease

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; HEART MUSCLE ISCHEMIA; HUMAN; MALE; NON INVASIVE MEASUREMENT; PARTICLE SIZE; PREDICTION; RISK ASSESSMENT; RISK FACTOR; ROC CURVE; SCORING SYSTEM;

ADULT; AGE FACTORS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; HUMANS; LOGISTIC MODELS; MALE; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SMOKING; TURKEY;

EID: 56049099055     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.63.5.2033231     Document Type: Article

References (24)

1. Mackay J, Mensah G. Deaths from coronary artery disease Atlas of Heart Disease and Stroke. World Health Organization 2004, p. 49.
2. Smith SC, Jr. Current and future directions of cardiovascular risk prediction. Am J Cardiol 2006; 97: 28A-32A.
3. Greenland P, Smith SC, Jr., Grundy SM. Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation 2001; 104: 1863-7.
4. Wierzbicki AS, Reynolds TM, Gill K, Alg S, Crook MA. A comparison of algorithms for initiation of lipid lowering therapy in primary prevention of coronary heart disease. J Cardiovasc Risk 2000; 7: 63-71.
5. Zarich S, Luciano C, Hulford J, Abdullah A. Prevalence of metabolic syndrome in young patients with acute MI: does the Framingham Risk Score underestimate cardiovascular risk in this population? Diab Vasc Dis Res 2006; 3: 103-7.
6. Lamm G, Auer J, Weber T, Berent R, Lassnig E, Eber B. Cardiovascular risk factor profiles and angiography results in young patients. Acta Med Austriaca 2003; 30: 72-5.
7. Chouhan L, Hajar HA, Pomposiello JC. Comparison of thrombolytic therapy for acute myocardial infarction in patients aged < 35 and > 55 years. Am J Cardiol 1993; 71: 157-9.
8. Uddin SN, Begum F, Malik F, Rahman S. Coronary artery disease in young patients: clinical review and risk factor analysis. Mymensingh Med J 2003; 12: 3-7.
9. Koz C, Uzun M, Yokusoglu M, Baysan O, Erinc K, Sag C, Hasimi A, Isik E. Evaluation of plasma adiponectin levels in young men with coronary artery disease. Acta Cardiol 2007; 62: 239-43.
10. Tsukamoto H, Takei I, Ishii K, Watanabe K. Simplified method for the diameter sizing of serum low-density lipoprotein using polyacrylamide gradient gel electrophoresis. Clin Chem Lab Med 2004; 42: 1009-12.
11. Schisterman EF, Whitcomb BW. Coronary age as a risk factor in the modified Framingham risk score. BMC Med Imaging 2004; 4: 1.
12. Satoh H, Nishino T, Tomita K, Saijo Y, Kishi R, Tsutsui H. Risk factors and the incidence of coronary artery disease in young middle-aged Japanese men: results from a 10-year cohort study. Intern Med 2006; 45: 235-9.
13. Sonmez K, Akcay A, Akcakoyun M, Demir D, Elonu OH, Pala S, Duran NE, Gencbay M, Degertekin M, Turan F. Distribution of risk factors and prophylactic drug usage in Turkish patients with angiographically established coronary artery disease. J Cardiovasc Risk 2002; 9: 199-205.
14. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
15. Despres JP, Lemieux I, Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ 2001; 322: 716-20.
16. St-Pierre J, Lemieux I, Perron P, Brisson D, Santure M, Vohl MC, Despres JP, Gaudet D. Relation of the "hypertriglyceridemic waist" phenotype to earlier manifestations of coronary artery disease in patients with glucose intolerance and type 2 diabetes mellitus. Am J Cardiol 2007; 99: 369-73.
17. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001; 358: 2026-33.
18. Lamarche B, Moorjani S, Lupien PJ, Cantin B, Bernard PM, Dagenais GR, Despres JP. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study. Circulation 1996; 94: 273-8.
19. Grundy SM. Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy. Circulation 2002; 106: 2526-9.
20. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-52.
21. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988; 260: 1917-21.
22. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990; 82: 495-506.
23. Coresh J, Kwiterovich PO, Jr., Smith HH, Bachorik PS. Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res 1993; 34: 1687-97.
24. Tsimikas S, Willerson JT, Ridker PM. C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol 2006; 47: C19-31.